124 related articles for article (PubMed ID: 3772718)
1. Effect of piperidine and related alicyclic amines on nicotinic and muscarinic agonist binding sites in the mammalian brain.
Yamada S; Kagawa Y; Ushijima H; Takayanagi N; Hayashi E
J Pharmacobiodyn; 1986 Jul; 9(7):620-5. PubMed ID: 3772718
[TBL] [Abstract][Full Text] [Related]
2. Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparations.
Repond C; Pratt JA; Stolerman IP; Mayer JM; Jenner P; Marsden CD; Testa B
Arzneimittelforschung; 1986 Aug; 36(8):1191-4. PubMed ID: 3778556
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.
Zhang X; Tian JY; Svensson AL; Gong ZH; Meyerson B; Nordberg A
J Neural Transm (Vienna); 2002 Mar; 109(3):377-92. PubMed ID: 11956958
[TBL] [Abstract][Full Text] [Related]
4. Neosurugatoxin, a specific antagonist of nicotinic acetylcholine receptors.
Hayashi E; Isogai M; Kagawa Y; Takayanagi N; Yamada S
J Neurochem; 1984 May; 42(5):1491-4. PubMed ID: 6707649
[TBL] [Abstract][Full Text] [Related]
5. Brain nicotine cholinoceptor binding in spontaneous hypertension.
Yamada S; Kagawa Y; Ushijima H; Takayanagi N; Tomita T; Hayashi E
Brain Res; 1987 May; 410(2):212-8. PubMed ID: 3594235
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the hexamethonium derivative W84, an allosteric effector at muscarinic cholinoreceptors, with rat brain nicotinic binding sites.
Leithäuser F; Mohr K; Staschen CM
Pharmacol Toxicol; 1990 Oct; 67(4):317-21. PubMed ID: 2077524
[TBL] [Abstract][Full Text] [Related]
7. Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin.
Yamada S; Isogai M; Kagawa Y; Takayanagi N; Hayashi E; Tsuji K; Kosuge T
Mol Pharmacol; 1985 Aug; 28(2):120-7. PubMed ID: 2862574
[TBL] [Abstract][Full Text] [Related]
8. Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro.
Costa LG; Murphy SD
Clin Exp Pharmacol Physiol; 1984; 11(6):649-54. PubMed ID: 6536422
[TBL] [Abstract][Full Text] [Related]
9. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
11. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.
Copeland JR; Adem A; Jacob P; Nordberg A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):123-7. PubMed ID: 2067586
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic cholinoceptors in the rabbit's myometrium: a study of the relationship between binding and response.
Crankshaw DJ
Eur J Pharmacol; 1984 May; 101(1-2):1-10. PubMed ID: 6745315
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of some pyridine, piperidine, and pyrrolidine analogues for enhancing and inhibiting the binding of (+/-)-[3H]nicotine to the rat brain P2 preparation.
Sloan JW; Martin WR; Hook R; Hernandez J
J Med Chem; 1985 Sep; 28(9):1245-51. PubMed ID: 4032427
[TBL] [Abstract][Full Text] [Related]
17. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.
Lapchak PA; Araujo DM; Quirion R; Collier B
J Neurochem; 1989 Feb; 52(2):483-91. PubMed ID: 2911027
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs.
Nordberg A; Romanelli L; Sundwall A; Bianchi C; Beani L
Br J Pharmacol; 1989 Sep; 98(1):71-8. PubMed ID: 2804554
[TBL] [Abstract][Full Text] [Related]
20. Influence of development and aging on nicotinic receptor subtypes in rodent brain.
Zhang X; Wahlström G; Nordberg A
Int J Dev Neurosci; 1990; 8(6):715-21. PubMed ID: 2288245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
